
Congress should reauthorize Hospital-at-Home
Get The Gavel
A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr.
Enter Email
Sign Up
The Congressional Budget Office scored the Hospital-at-Home Program as
Advertisement
But these programs are at risk if Congress doesn't act.
That's because the at-home experiment was only possible because in 2020, during the COVID-19 pandemic, the Centers for Medicare and Medicaid Services issued a waiver requiring Medicare to reimburse for Hospital-at-Home care at the same rate as inpatient care. The waiver also let states reimburse via Medicaid, and Massachusetts is one of around a dozen states where Medicaid pays the same rate for at-home and inpatient care, according to the American Hospital Association. The waiver was extended in 2022 and 2024.
Federal regulators have approved Hospital-at-Home programs
Now, though, the waiver is set to expire Sept. 30, unless Congress approves a
Constantinos Michaelidis, medical director of Hospital at Home at UMass Memorial Health, said UMass started the program in August 2021 when patients were waiting hours for a hospital bed. Since then, around 3,600 patients have been cared for at home after presenting at one of three hospitals. According to data provided by UMass Memorial, compared to patients using its brick-and-mortar hospitals, Hospital-at-Home patients had 60 to 70 percent lower mortality, 15 to 30 percent higher patient satisfaction, 5 to 15 percent fewer readmissions, and 80 to 90 percent fewer transfers to skilled nursing facilities after discharge.
Michaelidis said he wants to eventually offer Hospital-at-Home throughout the system, and a five-year extension would provide the financial certainty to expand. 'These programs take a lot of money to get off the ground,' Michaelidis said. 'We need Congress to make sure if we spend $3 million expanding the program, it won't go away in two months.'
Advertisement
A similar calculation is underway at Beth Israel Lahey Health, which started offering Hospital-at-Home in August 2023 at Lahey Hospital and Medical Center. The program has grown gradually, as specialists in different fields established protocols for who can be served at home. It now admits around 100 patients a month, and the hospital recently started offering physical therapy virtually to at-home patients.
Sue Stempek, vice president of BILH Hospital at Home, said the system is considering expanding the program to additional hospitals, and a long-term waiver would allow for growth and for research studies to evaluate the model's effectiveness.
An open question is the cost impact. Today in Massachusetts, some commercial insurers pay inpatient rates; some pay less. Lora Pellegrini, president of the Massachusetts Association of Health Plans, said some insurers balk at paying inpatient rates when home care doesn't have the same overhead costs.
But hospital officials say start-up costs are hefty for staff, equipment, and technology.
South Shore Health closed its Hospital-at-Home program May 17, after 11 months. Chief of Medicine Jason Tracy said participants loved the program. But it took time for patients and clinicians to adjust to the idea, and when serving only five or six patients a day, the program lost millions of dollars. 'In this environment, you have to put your resources toward stronger financially performing programs that have greater patient demand,' Tracy said.
There are efficiencies in bigger hospital systems. Mass General Brigham has treated over 7,000 patients since January 2022 in Hospital-at-Home programs run through five hospitals. The health system saved 35,000 'bed days,' a measure of how many days inpatient beds would have been filled by those patients.
Advertisement
Heather O'Sullivan, MGB's president of Healthcare at Home, said the program has expanded to new patient populations — like those in post-operative recovery — and the federal waiver lets the hospital scale up knowing it can recoup costs. Without the waiver, O'Sullivan worried that all but the largest health systems would be unable to make those investments.
Congress should also ask federal regulators to study the costs associated with Hospital-at-Home, to determine whether insurance should continue to pay the same as for inpatient care or whether home hospital can achieve cost savings.
The need to study costs shouldn't prevent Congress from reauthorizing the waiver for five years, though. Hospital-at-Home provides the care patients want with improved health outcomes, while preserving beds for patients who need inpatient care. That's a win-win-win.
Editorials represent the views of the Boston Globe Editorial Board. Follow us
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
35 minutes ago
- Fox News
WATCH LIVE: Officials give update after shooter reported near Emory University in Atlanta
A spokesperson for Grady Hospital confirmed to FOX News that one police officer was sent to Emory University Hospital.


Axios
an hour ago
- Axios
What to know about rising COVID-19 cases and the surging "stratus" variant
COVID-19 cases are rising again in the United States, and the "stratus" variant might be to blame. The big picture: A summer outbreak of COVID-19 cases isn't a shocker. But it's arriving before children head back to school, where the virus could spread even more. The risk of a summertime COVID-19 wave comes after Health Secretary Robert F. Kennedy Jr. unilaterally changed federal COVID vaccine recommendations, causing confusion over who should get the shots. COVID-19 cases rising in U.S. Driving the news: The Centers for Disease Control and Prevention on Friday upgraded national wastewater viral activity for COVID-19 from "low" to "moderate." Wastewater levels for COVID-19 are highest in the Western U.S., according to a CDC map, with levels peaking in Alaska, California, Colorado, Nevada and Utah. The Southeast also has higher wastewater activity levels, with Louisiana having the most nationwide, according to CDC data recorded from July 27 to Aug. 2. What they're saying: "Wastewater monitoring can detect viruses spreading from one person to another within a community earlier than clinical testing and before people who are sick go to their doctor or hospital," the CDC says on its website. "It can also detect infections without symptoms. If you see increased wastewater viral activity levels, it might indicate that there is a higher risk of infection." By the numbers: The CDC estimated Friday that COVID-19 cases are likely growing across 45 states. Only four states — Alaska, North Dakota, Maine and New Hampshire — measured as having no change in COVID-19 cases. Wyoming's numbers were not estimated. Though the N.B.1.8.1 variant (nicknamed "nimbus") is still the dominant variant in the U.S., the recent climb might be related to the variant XFG, commonly known as "Stratus." Both are descendants of the Omicron strain. What to know about the "stratus" COVID variant Flashback: The XFG "stratus" variant was first dedicated in January, according to the World Health Organization. The variant made little noise in the United States during the first half of the year. However, in June, the "stratus" variant accounted for 14% of cases, according to the CDC, which is the third-highest among all variants. XFG is a combination of the LF.7 and LP.8.1.2 variants, the latter of which is the second-most prominent strain in the U.S., per the CDC. Yes, but: Though the WHO has placed XFG on its watchlist, and it may be more adept at evading our immune defenses, the "stratus" variant was deemed as a "low" public health risk as recent as June. Are "Stratus" variant symptoms different? The "stratus" variant symptoms haven't been seen as any different than other recent COVID-19 variants. The common COVID-19 symptoms outlined by the CDC — fever, chills, cough, sore throat and congestion — still apply.


Newsweek
2 hours ago
- Newsweek
Medicare Will Start Using AI to Help Make Coverage Decisions Next Year
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services (CMS) will use AI to help make prior authorization decisions via the new Wasteful and Inappropriate Service Reduction (WISeR) Model, but the final decision will be made by an employee, according to the agency. Why It Matters AI has made a significant impact in the workforce, education, health care and beyond. While some remain hesitant about its usage and the possibility of it eliminating human jobs, AI tools have been linked to greater efficiency for many companies. While traditional Medicare has typically had fewer prior authorization requirements than Medicare Advantage, the use of AI could speed up coverage decisions and also potentially lead to higher denials of coverage, experts say. A sign in front of the Centers for Medicare & Medicaid Services building is pictured on March 19 in Woodlawn, Maryland. A sign in front of the Centers for Medicare & Medicaid Services building is pictured on March 19 in Woodlawn, To Know While the final decision by Medicare to approve or deny coverage will come down to an employee, critics of the AI test pilot say that companies conducting the review process will be incentivized to deny coverage because they receive payments when they lower costs. The move toward AI arrives as the Trump administration has made it a priority to reduce government fraud and waste, and Medicare Part B premiums are likely to increase by $21.50 per month, from $185 in 2025 to $206.50 in 2026, according to MarketWatch. Some of the specific services included in the AI-powered prior authorization decisions will be skin and tissue substitutes, electrical nerve-stimulator implants and knee arthroscopy for knee osteoarthritis. In the past, traditional Medicare enrollees face fewer prior authorization decisions. The average number of them required per Medicare Advantage enrollee was two in 2023, compared to just one review per 100 traditional Medicare beneficiaries. "For seniors, the impact could be substantial, especially when immediate care is critical," Kevin Thompson, CEO of 9i Capital Group and host of the 9innings podcast, told Newsweek. "The current administration is focused on removing so-called waste, fraud, and abuse, pulling every lever to show their program is working. What used to require a single prior authorization could now face multiple layers, which means more delays and higher denial rates." The AI pilot will take place over the next six years and will not apply to inpatient-only services or for procedures that carry high risks if delayed. At the moment, the pilot program is limited to Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington. What People Are Saying CMS Administrator Dr. Mehmet Oz, in a statement: "CMS is committed to crushing fraud, waste, and abuse, and the WISeR Model will help root out waste in Original Medicare. Combining the speed of technology and the experienced clinicians, this new model helps bring Medicare into the 21st century by testing a streamlined prior authorization process, while protecting Medicare beneficiaries from being given unnecessary and often costly procedures." Alex Beene, financial literacy instructor for the University of Tennessee at Martin, told Newsweek: "For many Americans, the term 'Medicare Advantage' has left them asking what the real advantage was, as plans haven't worked out in some parts of the country as efficiently as originally promised. With that in mind, the announcement Medicare will start piloting the use of AI as a possible pre-authorization procedure for potential recipients in six states and the citing of Medicare Advantage's additional authorization steps is raising concerns - and rightfully so." Thompson also told Newsweek: "AI may speed up processing times in theory, but mistakes are inevitable. The bigger concern is how the financial incentives are structured. If contractors are rewarded for reducing or denying coverage, that's exactly what will happen—more denials. It's as simple as following the money. Whether a treatment is truly necessary or not becomes secondary to the incentive structure." What Happens Next The AI usage could have significant impacts on the number of procedures that Medicare beneficiaries get approved for coverage. According to a 2024 Senate committee report, AI tools have been linked to higher rates of care denial, 16 times higher than decisions made without the technology. "Medicare recipients want an easy process with as many barriers removed as possible when qualifying and receiving services," Beene said. "AI can certainly be used to refine the process, but as it's been presented, there's justification for the red flags being raised."